Class information for:
Level 1: CISPLATIN RESISTANCE//PLATINUM DNA ADDUCTS//HUMAN OVARIAN CANCER CELL LINE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
11215 933 37.3 77%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1055 9558 CISPLATIN//NAMI A//NEPHROTOXICITY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CISPLATIN RESISTANCE Author keyword 16 20% 7% 69
2 PLATINUM DNA ADDUCTS Author keyword 7 53% 1% 9
3 HUMAN OVARIAN CANCER CELL LINE Author keyword 4 67% 0% 4
4 RAT OVARIAN TUMOR CELL LINES Author keyword 4 75% 0% 3
5 DWA2114R Author keyword 3 50% 0% 4
6 GENE SPECIFIC DAMAGE Author keyword 2 67% 0% 2
7 ORAL SQUAMOUS CELL CARCINOMA CELL LINES Author keyword 2 67% 0% 2
8 PRSVCAT Author keyword 2 67% 0% 2
9 CISPLATIN ACCUMULATION Author keyword 2 50% 0% 3
10 THALIBLASTINE Author keyword 2 50% 0% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CISPLATIN RESISTANCE 16 20% 7% 69 Search CISPLATIN+RESISTANCE Search CISPLATIN+RESISTANCE
2 PLATINUM DNA ADDUCTS 7 53% 1% 9 Search PLATINUM+DNA+ADDUCTS Search PLATINUM+DNA+ADDUCTS
3 HUMAN OVARIAN CANCER CELL LINE 4 67% 0% 4 Search HUMAN+OVARIAN+CANCER+CELL+LINE Search HUMAN+OVARIAN+CANCER+CELL+LINE
4 RAT OVARIAN TUMOR CELL LINES 4 75% 0% 3 Search RAT+OVARIAN+TUMOR+CELL+LINES Search RAT+OVARIAN+TUMOR+CELL+LINES
5 DWA2114R 3 50% 0% 4 Search DWA2114R Search DWA2114R
6 GENE SPECIFIC DAMAGE 2 67% 0% 2 Search GENE+SPECIFIC+DAMAGE Search GENE+SPECIFIC+DAMAGE
7 ORAL SQUAMOUS CELL CARCINOMA CELL LINES 2 67% 0% 2 Search ORAL+SQUAMOUS+CELL+CARCINOMA+CELL+LINES Search ORAL+SQUAMOUS+CELL+CARCINOMA+CELL+LINES
8 PRSVCAT 2 67% 0% 2 Search PRSVCAT Search PRSVCAT
9 CISPLATIN ACCUMULATION 2 50% 0% 3 Search CISPLATIN+ACCUMULATION Search CISPLATIN+ACCUMULATION
10 THALIBLASTINE 2 50% 0% 3 Search THALIBLASTINE Search THALIBLASTINE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CIS DIAMMINEDICHLOROPLATINUMII 61 20% 30% 278
2 ENHANCED DNA REPAIR 42 74% 3% 31
3 CIS DIAMMINEDICHLOROPLATINUMII ACCUMULATION 31 60% 4% 34
4 DAMAGED PLASMID DNA 18 89% 1% 8
5 DAMAGE RECOGNITION PROTEINS 13 71% 1% 10
6 PATIENTS RECEIVING CARBOPLATIN 9 83% 1% 5
7 DISEASE RESPONSE 9 67% 1% 8
8 MURINE LEUKEMIA L1210 CELLS 5 60% 1% 6
9 CISPLATIN CYTO TOXICITY 5 63% 1% 5
10 LEUKOCYTE DNA 4 18% 2% 22

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
CELLULAR ACCUMULATION OF THE ANTICANCER AGENT CISPLATIN - A REVIEW 1993 360 33 67%
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy 2008 161 192 23%
DNA repair: Enzymatic mechanisms and relevance to drug response 1996 179 227 26%
CELLULAR PHARMACOLOGY OF CISPLATIN - PERSPECTIVES ON MECHANISMS OF ACQUIRED-RESISTANCE 1990 412 68 49%
MODULATION OF CIS-DIAMMINEDICHLOROPLATINUM(II) RESISTANCE - A REVIEW 1992 165 109 44%
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes 2012 87 136 13%
Mechanisms of resistance to cisplatin and carboplatin 2007 241 306 12%
Insights into mechanisms of cisplatin resistance and potential for its clinical reversal 1996 67 172 33%
Systems biology of cisplatin resistance: past, present and future 2014 25 300 7%
Glutathione and drug resistance 1996 62 90 34%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BIOPHYS CYTOCHEM 1 100% 0.2% 2
2 KLIN DIEREXPT 1 100% 0.2% 2
3 REGULATORY CELL SYST 1 25% 0.3% 3
4 PATERSON S 1 50% 0.1% 1
5 PHARMACEUT BIOCHEM MOL BIOL BIOTECHNOL 1 50% 0.1% 1
6 SURG PERIOPERAT SCI CARDIOTHORAC SURG 1 50% 0.1% 1
7 UNITE PHYSICOCHIM PHARMACOL MACROMOL BIOL 1 50% 0.1% 1
8 CANC UK MED 0 33% 0.1% 1
9 CHIRURG CERVICO IALE ORL 0 33% 0.1% 1
10 MARY KAY ASH CANC 0 33% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000189525 PLATINUM BASED DRUG//JM216//PLATINUM COMPLEXES
2 0.0000158341 FRACTIONATED X IRRADIATION//RAT YOLK SAC TUMOR//DRUG EFFECT ON BRAIN
3 0.0000140407 LIPOSOMAL CISPLATIN//LIPOPLATIN//SPI 077
4 0.0000135381 ERCC1//RRM1//MED OVARIAN CANC SECT
5 0.0000128176 DIAZENES//DIAZENECARBOXAMIDES//BIOINORGAN CHEM S
6 0.0000127736 CALVERT FORMULA//CHATELUT FORMULA//SKI 2053R
7 0.0000119120 PEPTICHEMIO//ALKYLATING PEPTIDES//HUMAN MYELOMA CELLS
8 0.0000084435 NEPHROTOXICITY//SERV FARMACOL TOSSICOL//CISPLATIN NEPHROTOXICITY
9 0.0000076981 THERMORADIOSENSITIZATION//THERMAL RADIOSENSITIZATION//LONG DURATION MILD HYPERTHERMIA
10 0.0000069794 CA2 ANTAGONISTIC ACTION//INNOVAT PATHOPHYSIOL GRP//RAT PHRENIC NERVE